|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 877 CHF | -0.79% |
|
-0.11% | +2.04% |
| Apr. 02 | Health Care Down on Flight From Risk -- Health Care Roundup | DJ |
| Apr. 02 | European Midday Briefing : Stocks Gain as Bonds Track Treasuries Lower | DJ |
Sept 9 (Reuters) - The European Union's drugs regulator on Thursday approved an increase in manufacturing capacity for the COVID-19 vaccine from Pfizer/BioNTech , which would help produce up to 50 million additional doses this year.
Both approved sites are located in Germany. One of them is operated by Sanofi-Aventis Deutschland Gmb and the other is operated by Siegfried Hameln GmbH, the European Medicines Agency said. (Reporting by Pushkala Aripaka in Bengaluru; Editing by Arun Koyyur)
Price
|
Change
|
5d. change
|
Capi.
| ||
|---|---|---|---|---|---|
| 88.09 USD | -0.45% | +1.96% | 21.33B | ||
| 87.7 EUR | -1.29% | +1.76% | 119B | ||
| 1st Jan change | Capi. | |
|---|---|---|
| +2.04% | 4.16B | |
| +25.61% | 672B | |
| +25.87% | 570B | |
| -5.24% | 360B | |
| +16.49% | 321B | |
| +8.28% | 300B | |
| +7.09% | 217B | |
| -9.12% | 204B | |
| +5.01% | 199B | |
| -8.75% | 149B |
SIEGFRIED HOLDING AG 
